Skip to content
value.today
Orthofix Medical Inc. logo

Orthofix Medical Inc.

OFIX
$377 Mmarket cap on Oct 15, 2026-21.1% since Jan 2024
Compare
World rank
#13,802
Revenue
$822 M
For year ending December-2025
Net income
$-92 M
-11.2% margin
SEC filing
Employees
—

Orthofix Medical Inc. in brief

Orthofix Medical Inc. is a listed company in the Medical Devices industry, based in Lewisville, Texas, USA. Its market value was $377 M on 15 October 2026, which makes it the 13,802nd largest listed company in the world and the 2,709th largest in the USA on this site. In the year to December 2025 it had sales of $822 M and a net loss of $92 M. Massimo Calafiore is its chief executive. Its largest business segments by sales in 2025 were Global Spine (84%) and Global Limb Reconstruction (16%). By market, the largest shares of its 2025 sales came from USA (83%), Italy (3%) and UK (2%). Its shares trade under the symbol OFIX (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Orthofix Medical Inc.

Orthofix Medical is a diversified, global medical device company focused on improving patients lives by providing superior reconstruction and regenerative orthopedic and spine solutions to physicians worldwide. The company products are distributed in more than 70 countries around the world via Orthofix sales representatives, stocking distributors and subsidiaries. It has more than 1000 employees around the world are dedicated to the development, manufacturing and distribution of orthopedic and spine products and regenerative tissue forms. The headquarters is in USA.

Orthofix Medical Inc. timeline

4 events, 1992–2025
  1. 1992
  2. 🔔
    · approximate
    Initial public offering on Nasdaq
  3. 1998
  4. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  5. 2018
  6. ✎
    Renamed Orthofix Medical Inc.
    Formerly Orthofix International N V.
  7. 2025
  8. 💰
    Record revenue of $822 million
    FY2025, the highest of the 8 years on record.

Events of Orthofix Medical Inc. from the company record, SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$238 M$475 M$713 M$950 M2020202120222023202420252026

World rank over time

▼ down 5,630 places since 2020
2020-01-01: #8218#8,21820202021-01-01: #8739#8,73920212022-01-07: #12189#12,18920222022-12-25: #14094#14,09420222023-07-30: #10632#10,63220232024-01-05: #12888#12,88820242026-03-08: #6970#6,97020262026-08-01: #12918#12,91820262026-09-28: #13804#13,80420262026-10-15: #13848#13,8482026

Rank in USA: #2,042 (Jan 2020) · #2,355 (Jan 2021) · #3,035 (Jan 2022) · #2,889 (Dec 2022) · #2,390 (Jul 2023) · #2,576 (Jan 2024) · #1,225 (Mar 2026) · #2,632 (Aug 2026) · #2,696 (Sep 2026) · #2,713 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
n/m (loss)
Price / sales (TTM)
0.5×
Price / book
0.8×
Free cash flow yield
-0.3%
Net margin (TTM)
-5.4%
Operating margin
-9.9%
Return on equity
-10.0%
Liabilities / assets
47.1%
Net debt
$75M
Revenue growth
+2.9%
R&D / revenue
8.0%

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2018: revenue $453M, net income $14M$453MFY18Fiscal year ending Dec 2019: revenue $460M, net income $-28M$460MFY19Fiscal year ending Dec 2020: revenue $407M, net income $3M$407MFY20Fiscal year ending Dec 2021: revenue $464M, net income $-38M$464MFY21Fiscal year ending Dec 2022: revenue $461M, net income $-20M$461MFY22Fiscal year ending Dec 2023: revenue $747M, net income $-151M$747MFY23Fiscal year ending Dec 2024: revenue $799M, net income $-126M$799MFY24Fiscal year ending Dec 2025: revenue $822M, net income $-92M$822MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$822M+2.9%$-81M$-92M-11.2%
Dec 2024$799M+7.1%$-85M$-126M-15.8%
Dec 2023$747M+62.1%$-139M$-151M-20.3%
Dec 2022$461M-0.8%$-13M$-20M-4.3%
Dec 2021$464M+14.2%$-8M$-38M-8.3%
Dec 2020$407M-11.6%$-6M$3M0.6%
Dec 2019$460M+1.5%$-19M$-28M-6.2%
Dec 2018$453M—$30M$14M3.0%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$33M$35M$-1M$-2.33—
Dec 2024$26M$35M$-9M$-3.30—
Dec 2023$-46M$60M$-106M$-4.12—
Dec 2022$-12M$21M$-33M$-0.98—
Dec 2021$18M$18M$1M$-1.95—
Dec 2020$74M$15M$59M$0.13—
Dec 2019$32M$19M$13M$-1.51—
Dec 2018$50M$14M$36M$0.72—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$835M
Net income, trailing 12 months
$-45M
RevenueNet income
Three months to Dec 2024 (from the annual report): revenue $216M, net income $-29M$216MDec ’24Three months to Mar 2025: revenue $194M, net income $-53M$194MMar ’25Three months to Jun 2025: revenue $203M, net income $-14M$203MJun ’25Three months to Sep 2025: revenue $206M, net income $-23M$206MSep ’25Three months to Dec 2025 (from the annual report): revenue $220M, net income $-2M$220MDec ’25Three months to Mar 2026: revenue $197M, net income $-21M$197MMar ’26Three months to Jun 2026: revenue $211M, net income $-16M$211MJun ’26Three months to Sep 2026: revenue $208M, net income $-6M$208MSep ’26

Latest quarter to Sep 2026: revenue $208M (+1.1% on a year earlier), net income $-6M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of Orthofix Medical Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$822 M
Operating income
$-81 M
Net income
$-92 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$851 M
Total liabilities
$401 M
Total equity
$450 M

As of December-2025

Top 100 institutional investors in Orthofix Medical Inc.#

As of Sep 30, 2026
136 institutions held 39.4 M shares (about 96.7% of the shares outstanding) on Sep 30, 2026. The ten largest hold 69.8%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Orthofix Medical Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1Juniper Investment Company, LLC4,792,043+349,500 (+7.87%)11.76%$45 MNov 16, 2026
2Engine Capital Management, LP4,575,6750 (0.00%)11.23%$43 MNov 16, 2026
3BlackRock, Inc.3,863,335+536,775 (+16.14%)9.48%$36 MNov 13, 2026
4Rubric Capital Management LP3,721,7150 (0.00%)9.13%$35 MNov 16, 2026
5Armistice Capital, LLC3,624,000+360,000 (+11.03%)8.89%$34 MNov 16, 2026
6Paradigm Capital Management Inc/ny3,293,899-6,600 (-0.20%)8.08%$31 MNov 13, 2026
7Vanguard Capital Management LLC1,702,701-28,407 (-1.64%)4.18%$16 MNov 13, 2026
8State Street Corp1,001,547+48,399 (+5.08%)2.46%$9 MNov 12, 2026
9Millennium Management LLC949,339+87,309 (+10.13%)2.33%$9 MNov 16, 2026
10Geode Capital Management, LLC925,350-122,731 (-11.71%)2.27%$9 MNov 6, 2026
11Acadian Asset Management LLC842,531-44,669 (-5.03%)2.07%$8 MNov 9, 2026
12Dimensional Fund Advisors LP671,870-59,768 (-8.17%)1.65%$6 MNov 4, 2026
13AQR Capital Management LLC651,212-236,070 (-26.61%)1.60%$6 MNov 16, 2026
14Goldman Sachs Group Inc600,123+153,983 (+34.51%)1.47%$6 MNov 16, 2026
15Morgan Stanley597,966+302,310 (+102.25%)1.47%$6 MNov 13, 2026
16Jacobs Levy Equity Management, Inc430,713-50,123 (-10.42%)1.06%$4 MNov 16, 2026
17Bank Of America Corp /de/404,395+112,568 (+38.57%)0.99%$4 MNov 16, 2026
18Vanguard Portfolio Management LLC399,058-5,781 (-1.43%)0.98%$4 MNov 13, 2026
19Northern Trust Corp357,994-5,890 (-1.62%)0.88%$3 MNov 16, 2026
20AYAL Capital Advisors Ltd341,588-433,833 (-55.95%)0.84%$3 MNov 16, 2026
21FMR LLC320,690+55,213 (+20.80%)0.79%$3 MNov 10, 2026
22Charles Schwab Investment Management Inc306,119-28,498 (-8.52%)0.75%$3 MNov 16, 2026
23Russell Investments Group, Ltd.274,157+74,838 (+37.55%)0.67%$3 MNov 6, 2026
24Vanguard Fiduciary Trust Co270,194+2,885 (+1.08%)0.66%$3 MNov 13, 2026
25Tudor Investment Corp Et Al267,881-1,157 (-0.43%)0.66%$3 MNov 16, 2026
Show all 100: investors 26 to 100
Institutional investors 26 to 100 in Orthofix Medical Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26Bridgeway Capital Management, LLC240,953+128,348 (+113.98%)0.59%$2 MNov 16, 2026
27UBS Group AG212,748+24,747 (+13.16%)0.52%$2 MNov 10, 2026
28Arrowstreet Capital, Limited Partnership199,762-144,443 (-41.96%)0.49%$2 MNov 13, 2026
29GAMCO Investors, Inc. Et Al198,8000 (0.00%)0.49%$2 MNov 12, 2026
30Voya Investment Management LLC197,930+81,298 (+69.70%)0.49%$2 MNov 10, 2026
31Creative Planning191,417+177,506 (+1276.01%)0.47%$2 MNov 2, 2026
32Lazard Asset Management LLC171,820-2,082 (-1.20%)0.42%$2 MNov 16, 2026
33Jpmorgan Chase & Co163,572-1,294 (-0.78%)0.40%$2 MNov 12, 2026
34Empowered Funds, LLC138,453+103,348 (+294.40%)0.34%$1 MNov 13, 2026
35Point72 Asset Management, L.P.133,761+60,740 (+83.18%)0.33%$1 MNov 16, 2026
36Y-Intercept (Hong Kong) Ltd131,898+71,367 (+117.90%)0.32%$1 MOct 16, 2026
37Bank of New York Mellon Corp121,232+2,103 (+1.77%)0.30%$1 MNov 5, 2026
38Victory Capital Management Inc119,772+17,736 (+17.38%)0.29%$1 MNov 10, 2026
39Gabelli Funds LLC109,3000 (0.00%)0.27%$1 MNov 12, 2026
40Nuveen, LLC107,368-79,425 (-42.52%)0.26%$1 MNov 10, 2026
41Price T Rowe Associates Inc /MD/104,9980 (0.00%)0.26%$1 MNov 16, 2026
42Deutsche Bank AG\87,362-4,946 (-5.36%)0.21%$1 MNov 6, 2026
43Ameriprise Financial Inc83,941+3,123 (+3.86%)0.21%$1 MNov 16, 2026
44Renaissance Technologies LLC79,891-16,900 (-17.46%)0.20%$1 MNov 12, 2026
45American Century Companies Inc78,693+5,760 (+7.90%)0.19%$1 MNov 12, 2026
46Invesco Ltd.72,513-597 (-0.82%)0.18%$1 MNov 12, 2026
47Great Lakes Advisors, LLC70,035-65,206 (-48.21%)0.17%$1 MNov 6, 2026
48Algert Global LLC66,110New0.16%$1 MNov 17, 2026
49XTX Topco Ltd63,892+40,814 (+176.85%)0.16%$1 MNov 16, 2026
50Quantinno Capital Management LP60,053-23,235 (-27.90%)0.15%$1 MNov 13, 2026
51Global Strategic Investment Solutions, LLC57,8750 (0.00%)0.14%$1 MOct 16, 2026
52Rhumbline Advisers50,968-5,243 (-9.33%)0.13%$0 MNov 10, 2026
53Tejara Capital Ltd47,820-10,900 (-18.56%)0.12%$0 MNov 9, 2026
54BNP Paribas Financial Markets41,731-55,866 (-57.24%)0.10%$0 MNov 12, 2026
55Barclays PLC39,642+8,882 (+28.88%)0.10%$0 MNov 6, 2026
56Alliancebernstein L.P.38,749-4,400 (-10.20%)0.10%$0 MNov 16, 2026
57Boston Partners36,989+10,535 (+39.82%)0.09%$0 MNov 10, 2026
58Susquehanna Portfolio Strategies, LLC36,634-38,383 (-51.17%)0.09%$0 MNov 16, 2026
59State of Wyoming34,750+15,651 (+81.95%)0.09%$0 MOct 28, 2026
60Vanguard Global Advisers, LLC34,439+174 (+0.51%)0.08%$0 MNov 13, 2026
61CenterBook Partners LP33,988New0.08%$0 MNov 2, 2026
62Gsa Capital Partners LLP32,221+4,420 (+15.90%)0.08%$0 MNov 16, 2026
63Centiva Capital, LP31,139New0.08%$0 MNov 13, 2026
64RBF Capital, LLC30,0000 (0.00%)0.07%$0 MNov 13, 2026
65Mercer Global Advisors Inc /adv28,248-1,521 (-5.11%)0.07%$0 MNov 16, 2026
66Fox Run Management, L.L.C.26,919New0.07%$0 MNov 12, 2026
67D. E. Shaw & Co., Inc.25,735+14,335 (+125.75%)0.06%$0 MNov 16, 2026
68Ieq Capital, LLC25,479-11,789 (-31.63%)0.06%$0 MNov 10, 2026
69Mariner, LLC24,583-10,794 (-30.51%)0.06%$0 MNov 12, 2026
70Strs Ohio23,600+600 (+2.61%)0.06%$0 MOct 30, 2026
71Squarepoint Ops LLC22,753New0.06%$0 MNov 9, 2026
72Citigroup Inc22,630-15,638 (-40.86%)0.06%$0 MNov 4, 2026
73Assenagon Asset Management S.A.21,310-21,310 (-50.00%)0.05%$0 MOct 15, 2026
74MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.19,625+1,005 (+5.40%)0.05%$0 MNov 16, 2026
75Fifth Third Wealth Advisors LLC18,986New0.05%$0 MOct 22, 2026
76MetLife Investment Management, LLC18,528-5,399 (-22.56%)0.05%$0 MNov 16, 2026
77Wealth Enhancement Advisory Services, LLC13,956-3,944 (-22.03%)0.03%$0 MOct 13, 2026
78Engineers Gate Manager LP12,718New0.03%$0 MNov 16, 2026
79Quadrature Capital Ltd12,626New0.03%$0 MNov 13, 2026
80Teton Advisors, LLC12,500-4,000 (-24.24%)0.03%$0 MNov 12, 2026
81Manufacturers Life Insurance Company, The12,003-507 (-4.05%)0.03%$0 MNov 13, 2026
82Axq Capital, LP11,962New0.03%$0 MNov 12, 2026
83Police & Firemen's Retirement System of New Jersey10,6580 (0.00%)0.03%$0 MNov 9, 2026
84Vise Technologies, Inc.10,229New0.03%$0 MOct 29, 2026
85State Board Of Administration Of Florida Retirement System10,0720 (0.00%)0.02%$0 MNov 13, 2026
86New York State Common Retirement Fund8,1800 (0.00%)0.02%$0 MNov 17, 2026
87Aquatic Capital Management LLC8,144New0.02%$0 MNov 16, 2026
88Wells Fargo & Company/mn8,078-26,003 (-76.30%)0.02%$0 MNov 16, 2026
89Tower Research Capital LLC (TRC)7,688+4,385 (+132.76%)0.02%$0 MNov 16, 2026
90Arax Advisory Partners4,408-309 (-6.55%)0.01%$0 MNov 12, 2026
91HighMark Wealth Management LLC4,3100 (0.00%)0.01%$0 MNov 17, 2026
92Legal & General Group Plc4,0700 (0.00%)0.01%$0 MNov 16, 2026
93Ameritas Investment Partners, Inc.3,4940 (0.00%)0.01%$0 MNov 13, 2026
94Parallel Advisors, LLC3,269+3,140 (+2434.11%)0.01%$0 MNov 3, 2026
95Osaic Holdings, Inc.2,601+95 (+3.79%)0.01%$0 MNov 12, 2026
96Nisa Investment Advisors, LLC2,561-45 (-1.73%)0.01%$0 MOct 20, 2026
97Royal Bank Of Canada2,332+640 (+37.83%)0.01%$0 MNov 16, 2026
98Public Employees Retirement System Of Ohio1,803-36,290 (-95.27%)0.00%$0 MNov 16, 2026
99Rockefeller Capital Management L.P.1,656New0.00%$0 MNov 13, 2026
100Signaturefd, LLC1,482+984 (+197.59%)0.00%$0 MOct 23, 2026

All 136 institutional investors, with who bought and sold →

Mutual funds holding Orthofix Medical Inc.#

145 funds hold shares worth $83 M (about 21.0% of the company). Since their previous reports 65 added shares and 30 sold, buying $6 M net.
Mutual funds holding Orthofix Medical Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.1.21 M$11 M3.0%<0.01%+3.1%Jun 30, 2026
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors1.03 M$9 M2.5%0.01%+7.2%Jun 30, 2026
🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC440,869$5 M1.1%0.02%+15%Jul 31, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.473,856$4 M1.2%<0.01%+7.7%Jun 30, 2026
🇺🇸 Paradigm Micro-Cap FundPARADIGM FUNDS ADVISOR LLC400,000$4 M0.98%2.0%no changeJun 30, 2026
🇺🇸 iShares Russell 2000 Value ETFBlackRock Fund Advisors349,079$3 M0.86%0.02%+4.6%Jun 30, 2026
🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP180,783$2 M0.44%0.01%no changeJul 31, 2026
🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.201,328$2 M0.49%0.01%+4.6%May 31, 2026
🇺🇸 Goldman Sachs Small Cap Value Insights FundGoldman Sachs Asset Management, L.P.149,976$2 M0.37%0.13%+43%Jul 31, 2026
🇺🇸 Schwab U.S. Small-Cap ETFCharles Schwab Investment Management, Inc.189,113$2 M0.46%<0.01%−1.6%May 31, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC187,109$2 M0.46%<0.01%+1.0%May 31, 2026
🇺🇸 iShares U.S. Medical Devices ETFBlackRock Fund Advisors189,289$2 M0.46%0.06%+11%Jun 30, 2026
🇺🇸 1290 VT GAMCO Small Company Value PortfolioEquitable Investment Management Group, LLC185,000$2 M0.45%0.04%no changeJun 30, 2026
🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP120,099$1 M0.29%0.02%−8.1%Jul 31, 2026
🇺🇸 VIP Disciplined Small Cap PortfolioFidelity Management & Research Company LLC152,638$1 M0.37%0.21%+97%Jun 30, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors135,419$1 M0.33%0.08%+37%Jun 30, 2026
🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc.98,582$1 M0.24%0.02%+15%Jul 31, 2026
🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP90,212$1 M0.22%<0.01%−32%Jul 31, 2026
🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC90,143$1 M0.22%0.11%+37%Jul 31, 2026
🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP89,604$1 M0.22%<0.01%−20%Jul 31, 2026
🇺🇸 Fidelity Enhanced Small Cap Core ETFFidelity Management & Research Company LLC106,491$1 M0.26%0.02%newJun 30, 2026
🇺🇸 Paradigm Select FundPARADIGM FUNDS ADVISOR LLC100,000$1 M0.25%0.32%no changeJun 30, 2026
🇺🇸 The Gabelli Small Cap Growth FundGabelli Funds, LLC96,800$1 M0.24%0.05%−31%Jun 30, 2026
🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC96,082$1 M0.24%<0.01%no changeJun 30, 2026
🇺🇸 JPMorgan Small Cap Value FundJ.P. Morgan Investment Management Inc.96,026$1 M0.24%0.07%−5.7%Jun 30, 2026
🇺🇸 Vanguard Health Care Index FundThe Vanguard Group, Inc.94,025$1 M0.23%<0.01%−0.8%May 31, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC75,591$1 M0.19%0.01%+24%Jun 30, 2026
🇺🇸 Omni Small-Cap Value FundBridgeway Capital Management, LLC75,000$1 M0.18%0.05%newJun 30, 2026
🇺🇸 Multi-Manager Small Cap Equity Strategies FundColumbia Funds Series Trust I72,576$1 M0.18%0.05%+589%May 31, 2026
🇺🇸 State Street SPDR S&P Health Care Equipment ETFSSGA Funds Management, Inc.73,594$1 M0.18%0.44%+47%Jun 30, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC70,822$1 M0.17%<0.01%no changeMay 31, 2026
🇺🇸 iShares U.S. Small-Cap Equity Factor ETFBlackRock Fund Advisors52,608$1 M0.13%0.02%+7.8%Jul 31, 2026
🇺🇸 Avantis U.S. Small Cap Equity ETFAmerican Century ETF Trust65,308$1 M0.16%0.02%−17%May 31, 2026
🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC50,572$1 M0.12%0.01%no changeJul 31, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC60,186$1 M0.15%<0.01%+6.0%May 31, 2026
🇺🇸 Fidelity Small Cap Value Index FundFidelity Management & Research Company LLC55,939$1 M0.14%0.02%+17%Jun 30, 2026
🇺🇸 Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGoldman Sachs Asset Management, L.P.53,295$0 M0.13%0.05%−8.2%May 31, 2026
🇺🇸 iShares Core S&P Total U.S. Stock Market ETFBlackRock Fund Advisors52,948$0 M0.13%<0.01%+2.6%Jun 30, 2026
🇺🇸 Invesco RAFI US 1500 Small-Mid ETFInvesco Capital Management LLC39,483$0 M0.10%0.02%−10.0%Jul 31, 2026
🇺🇸 Inspire Small/Mid Cap ETFCWM Advisors, LLC47,055$0 M0.12%0.14%+48%May 31, 2026
🇺🇸 NVIT Multi-Manager Small Company FundNATIONWIDE FUND ADVISORS46,768$0 M0.11%0.09%+15%Jun 30, 2026
🇺🇸 NVIT Small Cap Value FundNATIONWIDE FUND ADVISORS43,107$0 M0.11%0.18%+13%Jun 30, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC40,719$0 M0.10%<0.01%no changeJun 30, 2026
🇺🇸 Voya Small Company PortfolioVoya Investments, LLC39,961$0 M0.10%0.17%+8.6%Jun 30, 2026
🇺🇸 Voya MI Dynamic Small Cap FundVoya Investments, LLC35,895$0 M0.09%0.18%+13%May 31, 2026
🇺🇸 EA Bridgeway Omni Small-Cap Value ETFEmpowered Funds, LLC d/b/a EA Advisers35,105$0 M0.09%0.01%newJun 30, 2026
🇺🇸 Small Cap Equity FundGuideStone Capital Management, LLC33,996$0 M0.08%0.03%−25%Jun 30, 2026
🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC24,835$0 M0.06%<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Russell 2000 Value Index FundThe Vanguard Group, Inc.31,138$0 M0.08%0.02%+9.9%May 31, 2026
🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc.22,050$0 M0.05%<0.01%no changeJul 31, 2026
🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC27,534$0 M0.07%0.01%+18%Jun 30, 2026
🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC21,334$0 M0.05%<0.01%no changeJul 31, 2026
🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation27,318$0 M0.07%0.01%no changeJun 30, 2026
🇺🇸 U.S. Vector Equity PortfolioDimensional Fund Advisors LP21,135$0 M0.05%<0.01%+227%Jul 31, 2026
🇺🇸 Vanguard U.S. Value Factor ETFThe Vanguard Group, Inc.25,943$0 M0.06%0.03%no changeMay 31, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC25,928$0 M0.06%<0.01%no changeMay 31, 2026
🇺🇸 Schwab U.S. Broad Market ETFCharles Schwab Investment Management, Inc.24,938$0 M0.06%<0.01%no changeMay 31, 2026
🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC19,325$0 M0.05%0.02%+14%Jul 31, 2026
🇺🇸 JPMorgan Small Cap Value PortfolioBrighthouse Investment Advisers, LLC23,621$0 M0.06%0.07%−14%Jun 30, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.21,491$0 M0.05%<0.01%no changeJun 30, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.21,185$0 M0.05%<0.01%+45%Jun 30, 2026
🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc.20,970$0 M0.05%0.01%+9.2%Jun 30, 2026
🇺🇸 Vanguard U.S. Multifactor ETFThe Vanguard Group, Inc.20,077$0 M0.05%0.03%no changeMay 31, 2026
🇺🇸 Small Cap Value FundThe Variable Annuity Life Insurance Company19,560$0 M0.05%0.07%−11%May 31, 2026
🇺🇸 U.S. Sustainability Core 1 PortfolioDimensional Fund Advisors LP15,120$0 M0.04%<0.01%no changeJul 31, 2026
🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC15,072$0 M0.04%<0.01%+6.5%Jul 31, 2026
🇺🇸 State Street SPDR US Small Cap Low Volatility Index ETFSSGA Funds Management, Inc.19,160$0 M0.05%0.07%+0.0%Jun 30, 2026
🇺🇸 T. Rowe Price Extended Equity Market Index FundT. Rowe Price Associates, Inc.17,980$0 M0.04%0.01%no changeJun 30, 2026
🇺🇸 Bridge Builder Small/Mid Cap Value FundOLIVE STREET INVESTMENT ADVISERS LLC17,050$0 M0.04%<0.01%no changeJun 30, 2026
🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company16,633$0 M0.04%0.01%no changeMay 31, 2026
🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC16,603$0 M0.04%0.06%−1.6%Jun 30, 2026
🇺🇸 TETON Westwood Mighty Mites FundTeton Advisors, LLC16,500$0 M0.04%0.07%−4.6%Jun 30, 2026
🇺🇸 Diversified Equity Alpha Master PortfolioBlackRock Fund Advisors16,237$0 M0.04%<0.01%+116%Jun 30, 2026
🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.15,772$0 M0.04%<0.01%+77%Jun 30, 2026
🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC15,085$0 M0.04%<0.01%+39%Jun 30, 2026
🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc.14,565$0 M0.04%<0.01%+2.1%Jun 30, 2026
🇺🇸 U.S. Core Equity 2 PortfolioDimensional Fund Advisors LP10,726$0 M0.03%<0.01%no changeJul 31, 2026
🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC13,566$0 M0.03%0.01%+6.5%Jun 30, 2026
🇺🇸 Vanguard U.S. Multifactor FundThe Vanguard Group, Inc.12,537$0 M0.03%0.04%no changeMay 31, 2026
🇺🇸 Gabelli Healthcare & WellnessRx TrustGabelli Funds, LLC12,500$0 M0.03%0.07%no changeJun 30, 2026
🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC10,313$0 M0.03%0.01%no changeJun 30, 2026
🇺🇸 Dimensional U.S. Equity Market ETFDimensional Fund Advisors LP7,374$0 M0.02%<0.01%no changeJul 31, 2026
🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC9,509$0 M0.02%0.01%+25%Jun 30, 2026
🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS9,352$0 M0.02%0.01%+19%Jun 30, 2026
🇺🇸 iShares Russell 3000 ETFBlackRock Fund Advisors9,122$0 M0.02%<0.01%−0.8%Jun 30, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC9,042$0 M0.02%0.04%+30%Jun 30, 2026
🇺🇸 Small Cap Core FundNorthern Trust Investments, Inc.8,826$0 M0.02%0.02%−4.5%Jun 30, 2026
🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC8,713$0 M0.02%<0.01%−24%Jun 30, 2026
🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC6,664$0 M0.02%<0.01%no changeJul 31, 2026
🇺🇸 Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC6,348$0 M0.02%0.02%+6.5%Jul 31, 2026
🇺🇸 Vanguard U.S. Quality Factor ETFThe Vanguard Group, Inc.7,557$0 M0.02%0.02%−58%May 31, 2026
🇺🇸 JNL/DFA U.S. Small Cap FundJackson National Asset Management, LLC7,069$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION6,953$0 M0.02%<0.01%no changeMay 31, 2026
🇺🇸 NVIT GS Small Cap Equity Insights FundNATIONWIDE FUND ADVISORS6,867$0 M0.02%0.03%newJun 30, 2026
🇺🇸 1290 VT Small Cap Value PortfolioEquitable Investment Management Group, LLC6,549$0 M0.02%0.01%+14%Jun 30, 2026
🇺🇸 Dimensional US Core Equity 1 ETFDimensional Fund Advisors LP5,000$0 M0.01%<0.01%+56%Jul 31, 2026
🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc.6,376$0 M0.02%0.01%+15%Jun 30, 2026
🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc.6,098$0 M0.01%0.01%+38%Jun 30, 2026
🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc.4,633$0 M0.01%<0.01%+2.9%Jul 31, 2026
🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC5,847$0 M0.01%0.01%+31%Jun 30, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 100 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Orthofix Medical Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$9.2 M
18 purchases, 5 insiders
Sold, 12 months
$6.6 M
29 sales, 9 insiders
Net, 12 months
$2.6 M
open market only
Insiders on file
60
since
$5.1 M-$2.7 M$0Dec 2024: bought $0 (0 trades), sold $464 (1 trades)Dec 24Jan 2025: bought $0 (0 trades), sold $427 K (7 trades)Feb 2025: bought $0 (0 trades), sold $17 K (2 trades)Mar 2025: bought $173 K (1 trades), sold $76 K (2 trades)MarApr 2025: bought $0 (0 trades), sold $52 K (2 trades)May 2025: bought $1.4 M (6 trades), sold $0 (0 trades)Jun 2025: bought $25 K (1 trades), sold $58 K (2 trades)JunJul 2025: bought $14 K (1 trades), sold $0 (0 trades)Aug 2025: bought $0 (0 trades), sold $28 K (1 trades)Jan 2026: bought $0 (0 trades), sold $371 K (3 trades)Jan 26Feb 2026: bought $1.7 M (4 trades), sold $0 (0 trades)Mar 2026: bought $62 K (3 trades), sold $412 K (15 trades)Apr 2026: bought $0 (0 trades), sold $48 K (1 trades)AprMay 2026: bought $2.3 M (9 trades), sold $2.6 M (1 trades)Jun 2026: bought $0 (0 trades), sold $34 K (1 trades)Aug 2026: bought $0 (0 trades), sold $416 K (3 trades)AugSep 2026: bought $0 (0 trades), sold $2.7 M (3 trades)Oct 2026: bought $0 (0 trades), sold $1 K (1 trades)Nov 2026: bought $5.1 M (2 trades), sold $1 K (1 trades)Nov
Bought (open market)Sold (open market)Hover a month for the totals
Orthofix Medical Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Juniper Investment Company, LLC10% ownerBuyindirect+14,803$7.040$104 K4.46 MForm 4
filed Juniper Investment Company, LLC10% ownerBuyindirect+675,000$7.411$5.0 M4.45 MForm 4
filed Patrick FisherPresident, Global Limb ReconSell10b5-1 plan-150$9.070$1 K50,769Form 4
filed Patrick FisherPresident, Global Limb ReconSell10b5-1 plan-150$9.440$1 K50,919Form 4
filed John A. Bartholdson10% ownerBuyindirect · amended+190,000$8.860$1.7 M3.77 MForm 4/A
filed Juniper Investment Company, LLC10% ownerSellindirect+190,000$8.860$1.7 M3.77 MForm 4
filed John A. Bartholdson10% ownerBuyindirect · amended+120,000$8.740$1.0 M3.58 MForm 4/A
filed Juniper Investment Company, LLC10% ownerSellindirect+120,000$8.740$1.0 M3.58 MForm 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Orthofix Medical Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
2.2 M
5.5% of shares · 6.12 days to cover
Buybacks, Q4 2016
$8.4M
Q4 2017
Shares sold short, last 24 reportsAll stocks →
Orthofix Medical Inc. share buybacks by quarter
Buybacks, quarterFiscalSpent
Q4 2016Q4 2017$8.4M
Q3 2016Q3 2016$11.1M
Q2 2016Q2 2017$17.4M
Q1 2016Q1 2017$26.5M
Q4 2013Q4 2013$0M
Q3 2013Q3 2013$12.6M

Fails to deliver

  • : 478 shares at $9.25
  • : 485 shares at $9.44
  • : 2,508 shares at $9.18
  • : 3,942 shares at $8.71
  • : 2,861 shares at $8.90

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Orthofix Medical Inc. scorecard#

Passes 8 of the 21 checks that could be worked out: strongest in growth (4 of 6), weakest in profitability (0 of 5). Fiscal year 2025; market cap of Oct 15, 2026.

  • Valuation2 of 5
    • ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
    • ✓Price to book below its peers' median0.8×Price to book 0.8× against Medical Devices's median of 2.5×.
    • ✓Price to sales below its peers' median0.5×Price to sales 0.5× against Medical Devices's median of 2.4×.
    • ✗Free cash flow yield above 5%-0.3%Free cash flow is -0.3% of the market value.
    • ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
    • –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
  • Growth4 of 6
    • ✓Revenue grew in the newest year2.9%Revenue up 2.9% in fiscal 2025.
    • ✓Revenue up more than 5% a year over three years21.3%21.3% a year over the three years to fiscal 2025.
    • ✓Faster growth over three years than its peers' median21.3%21.3% a year against Medical Devices's median of 10.8% (73 companies).
    • ✗Earnings per share grew in the newest year-2.33 vs -3.30Diluted EPS -2.33 in fiscal 2025 against -3.30 the year before (report's currency).
    • ✗Net income higher than five years earlier-$92 M-$92 M in fiscal 2025 against $3 M in 2020.
    • ✓Revenue rose in at least four of the last five years4 of 5Revenue rose in 4 of the five years to fiscal 2025.
  • Profitability0 of 5
    • ✗Profitable in the newest year-$92 MNet income -$92 M in fiscal 2025.
    • ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
    • ✗Operating margin above its peers' median-9.9%-9.9% against Medical Devices's median of -8.2% (86 companies).
    • ✗Return on equity above 15%-19.3%-19.3% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✗Operating margin wider than three years earlier-9.9%-9.9% in fiscal 2025 against -2.9% in 2022.
  • Financial health2 of 4
    • ✓Short-term assets cover short-term liabilities2.5×Current ratio 2.45 at the end of fiscal 2025.
    • ✓Debt below equity0.3×Debt to equity 0.35 at the end of fiscal 2025.
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years2 of 3Positive in 2 of the three years to fiscal 2025.
    • ✗Altman Z-score outside the distress zone0.96Z-score 0.96 (distress zone) for fiscal 2025.
  • Shareholder returns0 of 1
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✗Share count up no more than 2% in a year3.9%Diluted shares up 3.9% in fiscal 2025.
    • –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (sec), the medians of Medical Devices, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from Orthofix Medical Inc.'s statements, beside the median of Medical Devices.

Orthofix Medical Inc.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin-9.9%-8.2%
Net margin-11.2%-10.4%
Return on equity-19.3%-16.8%
Revenue growth, 3 years a year21.3%10.8%
Revenue growth2.9%10.4%
Debt to equity0.35×0.64×

5of 9on the Piotroski tests of financial strength

  • Net loss of $92 million, the 5th loss-making year in a row.
  • Free cash flow was negative: -$1 million.
  • Revenue has grown 3 years in a row.

Orthofix Medical Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Orthofix Medical Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020FY 2019to Dec 31, 2019FY 2018to Dec 31, 2018FY 2017to Dec 31, 2017FY 2016to Dec 31, 2016
Income statement
Revenue822799747461464407460453434410
Cost of revenue256254260124115102101979388
Gross profit566546486337350305359356341322
Research and development66748049503935333029
Selling, general and administrative554533530309——————
Selling and marketing——386229221204224206198181
General and administrative——1458069688683r72r76r
Operating expenses——————378326300301
Operating income−81−85−139−13−8.3−6.3−19304121
Net interest income−17−30−8.6−1.3−1.8−2.5−0.1−0.8−0.40.8
Provision for credit losses2.32.00.82.10.4—————
Other non-operating income (expense)8.1−9.6−0.9−3.2−3.38.4−8.1−6.4−4.0−2.8
Income before tax−91−124−149−18−13−0.4−27233619
Income tax1.42.12.72.025−2.91.49.12916
Income from continuing operations——————−28147.33.5
Net income attributable to shareholders−92−126−151−20−382.5−28146.23.1
Earnings per share, basic-2.33-3.30-4.12-0.98-1.950.13-1.510.730.340.17
Earnings per share, diluted-2.33-3.30-4.12-0.98-1.950.13-1.510.720.340.17
Shares, weighted average (basic)40383720201919181818
Shares, weighted average (diluted)40383720201919191818
Balance sheet
Cash and cash equivalents82833351889670708140
Receivables13613512883797287786358
Inventory172189222100838582778163
Other current assets24233222201721182619
Current assets417433420256270270261245252194
Property, plant and equipment12914015958596463434549
Right-of-use (leased) assets2217206.83.24.85.8———
Goodwill19519519571718471725454
Other intangible assets73991174753615452107.5
Total assets851893925459477526496467405372
Accounts payable58495828262320181814
Debt due within a year001.3———————
Current liabilities1701691658410610485867983
Long-term debt15715793———————
Lease liabilities (non-current)2514175.41.42.94.1———
Total liabilities401390327122140169168131109109
Retained earnings−368−276−1501.3215958877064
Shareholders' equity450503599337337357328335297263
Total liabilities and equity851893925459477526496467405372
Shares outstanding4038372020r1919r191818
Cash-flow statement
Depreciation and amortization77605329303125192021
Share-based compensation29323618151622191316
Cash from operating activities3326−46−121874325039r59r
Capital expenditure−35−35−60−21−18−15−19−14−15−16
Intangible assets bought——−1.8−1.8−1.8−1.6−1.5−1.7−2.3−1.9
Acquisitions, net of cash acquired———————−44——
Cash from investing activities−35−28−33−25−23−52−23−61−16−22
Shares issued5.96.35.14.38.87.6127.17.820
Shares bought back—————————−63
Cash from financing activities−0.85165−0.1−3.63.2−113.03.5−46
Exchange-rate effect on cash————————1.2−0.7
Change in cash−0.648−13−37−9.026−1.8−9.027r−9.7r
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What Orthofix Medical Inc. sells: revenue by product line, fiscal 2025#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.

Business segments

  • Global Spine$688 M84%
  • Global Limb Reconstruction$135 M16%

Countries and regions

Source: SEC annual report (XBRL data) · as of Dec 31, 2025

Where Orthofix Medical Inc. operates: 10 countries#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 11 subsidiaries on file.

Orthofix Medical Inc.: countries of operation
CountryPresenceRevenue there
🇺🇸 USAHeadquarters1 office1 subsidiary$684 M83%
🇨🇭 Switzerland2 subsidiaries—
🇦🇺 Australia1 subsidiary—
🇨🇦 Canada1 subsidiary—
🇳🇱 Netherlands1 subsidiary—
🇮🇹 Italy1 subsidiary$22 M2.7%
🇬🇧 UK$13 M1.6%
🇫🇷 France1 subsidiary$12 M1.4%
🇩🇪 Germany2 subsidiaries$9 M1.1%
🇧🇷 Brazil1 subsidiary$5 M0.6%

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

Executive pay at Orthofix Medical Inc.#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2025
$7.3 M
Massimo Calafiore
Other top executives, average
$2.2 M
the CEO earned 3.4× this
$100 invested is now
$35
peer group: $104
Orthofix Medical Inc.: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2025Massimo Calafiore$7.3 M$3.3 M$2.2 M$35 (peers $104)
2024Massimo Calafiore$10.6 M$14.6 M$2.7 M$38 (peers $150)
2023Massimo Calafiore$15.6 M$2.3 M$2.3 M$29 (peers $130)
2022Massimo Calafiore$6.3 M$5.0 M$2.1 M$44 (peers $121)
2021Massimo Calafiore$5.3 M$723 K$1.8 M$67 (peers $170)

Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025

Events at Orthofix Medical Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.

Directors and officers 7 · Material agreement 3 · Agreement ended 2 · New debt 1 · Shareholder vote 3 · Results announced 14

Orthofix Medical Inc.: events reported to the SEC
FiledWhat happenedFiling
Results announced8-K
Results announced8-K
Directors and officersShareholder vote8-K
Results announced8-K
Directors and officersResults announced8-K
Results announced8-K
Results announced8-K
Results announced8-K
Shareholder vote8-K
Results announced8-K
Material agreementAgreement ended8-K
Directors and officers8-K
Results announced8-K
Material agreementAgreement endedNew debt8-K
Results announced8-K
Results announced8-K
Directors and officersShareholder vote8-K
Results announced8-K
Material agreement8-K
Directors and officers8-K
Results announced8-K
Directors and officers8-K
Directors and officersResults announced8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 9, 2026

Acquisitions and funding#

1 acquisitions, $377 M paid where reported

Businesses it acquired

Acquisitions by Orthofix Medical Inc.
AcquiredAcquisition dateCompletionPriceStakeSource
SeaSpine Holdings Corporation2025—$377 M—Annual report

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

Layoffs at Orthofix Medical Inc.#

From US state WARN notices and SEC 8-K restructuring filings, newest first.

People, last 12 months
0
0 notices and filings
People, all years
0
2010–2010
Latest
—
2010-12-14
Orthofix Medical Inc.: people laid off by year and month
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2010············—
Orthofix Medical Inc.: latest layoffs
AnnouncedPeopleKindWhereSource
Not statedRestructuring planSEC 8-KCompany-wide planFiling

Source: State WARN notices and SEC 8-K item 2.05

How Orthofix Medical Inc. compares in Medical Devices

  • Market cap$377 M · higher than 46% of 142
  • Revenue$822 M · higher than 79% of 155
  • Net margin-5.4% · higher than 50% of 144
  • Revenue growth2.9% · higher than 27% of 104
  • Price / sales0.5× · lower than 96% of 96
  • Price / book0.8× · lower than 89% of 99
  • FCF yield-0.3% · higher than 55% of 76

Peer comparison · Medical Devices

CompanyMarket capP/ENet marginRev. growth
Orthofix Medical Inc.🇺🇸$377 M—-5.4%+2.9%
Abbott Laboratories🇺🇸$181.1 B38.5×9.8%+5.7%
Medtronic plc🇺🇸$121.2 B23.2×13.9%+8.4%
Stryker Corporation🇺🇸$116.5 B32.2×13.8%+11.2%
Boston Scientific Corporation🇺🇸$66.2 B18.9×16.6%+19.9%
Edwards Lifesciences Corporation🇺🇸$52.8 B51.7×15.3%+11.6%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.🇨🇳$27.8 B23.6×24.4%—
STERIS plc🇮🇪$20.4 B24.6×13.4%+8.7%
Zimmer Biomet Holdings, Inc.🇺🇸$18.2 B23.8×8.9%+7.2%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 15, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Orthofix Medical Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Orthofix Medical Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Orthofix Medical Inc.? Suggest a correction